China’s indigenous "artificial heart" saved two from advanced heart failure, setting a new record as patients survived over 100 days, state-run China Daily reported on Monday.
The auxiliary heart device was used in March by the doctors at the TEDA International Cardiovascular Hospital in Tianjin, northeast China.
A 39-year-old man and a 62-year-old woman, who were diagnosed with advanced dilated cardiomyopathy (DCM) -- a cardiovascular condition that enlarges the heart which then cannot pump blood effectively -- survived longer than any who had undergone the operation before.
HeartCon, a cardiovascular assisting device was developed and patented by China exclusively, is claimed to be the first entirely indigenous such device in the country, it was reported.
{"preview_thumbnail":"https://cdn.flowplayer.com/6684a05f-6468-4ecd-87d5-a748773282a3/i/v-i-f…","video_id":"f871c08e-0e4d-4810-b2bd-b75cab531cfe","player_id":"8ca46225-42a2-4245-9c20-7850ae937431","provider":"flowplayer","video":"Jordan: An Economic Deal Cannot Substitute for Peace"}
It was jointly developed by Chinese rocket technology developer, the Academy of Launch Vehicle Technology, and TEDA, with all components being produced in China.
The device weighs 180 grams (0.3 pounds) and is powered by two batteries.
The HeartCon was submitted for special review and approval procedure, the daily said, after being approved by the Chinese Food and Drug Administration in June 2018.
This article has been adapted from its original source.
